- Home
- VIVS vs SPRC Comparison
VIVS vs SPRC Comparison
Compare VIVS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- SPRC
- Stock Information
- Founded
- VIVS 2007
- SPRC 2004
- Country
- VIVS United States
- SPRC Israel
- Employees
- VIVS N/A
- SPRC N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- VIVS Health Care
- SPRC Health Care
- Exchange
- VIVS Nasdaq
- SPRC Nasdaq
- Market Cap
- VIVS 4.2M
- SPRC 3.4M
- IPO Year
- VIVS N/A
- SPRC N/A
- Fundamental
- Price
- VIVS $1.49
- SPRC $0.29
- Analyst Decision
- VIVS
- SPRC
- Analyst Count
- VIVS 0
- SPRC 0
- Target Price
- VIVS N/A
- SPRC N/A
- AVG Volume (30 Days)
- VIVS 63.3K
- SPRC 195.2K
- Earning Date
- VIVS 06-27-2025
- SPRC 02-15-2025
- Dividend Yield
- VIVS N/A
- SPRC N/A
- EPS Growth
- VIVS N/A
- SPRC N/A
- EPS
- VIVS N/A
- SPRC N/A
- Revenue
- VIVS $144,000.00
- SPRC $1,306,000.00
- Revenue This Year
- VIVS $42.38
- SPRC N/A
- Revenue Next Year
- VIVS $15.42
- SPRC N/A
- P/E Ratio
- VIVS N/A
- SPRC N/A
- Revenue Growth
- VIVS 32.11
- SPRC N/A
- 52 Week Low
- VIVS $1.41
- SPRC $0.20
- 52 Week High
- VIVS $21.96
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- SPRC 45.38
- Support Level
- VIVS N/A
- SPRC $0.29
- Resistance Level
- VIVS N/A
- SPRC $0.31
- Average True Range (ATR)
- VIVS 0.00
- SPRC 0.02
- MACD
- VIVS 0.00
- SPRC -0.00
- Stochastic Oscillator
- VIVS 0.00
- SPRC 17.33
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.